Corcept Therapeutics Market Sentiment

Corcept Therapeutics Inc

CORTNASDAQ

Trade with Public

$118.81

-2.38-1.96%

最終更新: Oct 13, 11:16 AM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Corcept Therapeutics Market Sentiment

Market sentiment signals for Corcept Therapeutics (CORT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 10.2% short float

Options Flow▼ 3.67 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

6 analysts

Options Flow (P/C)

3.67

More puts — Bearish

15 calls · 55 puts

Avg Consensus PT

$127

+7.0%

Highest Price Target

$165

+38.9%

Piper Sandler

Lowest Price Target

$50

-57.9%

Wolfe Research

Short Interest

10.2%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 18, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+38.9%	$165 → $165	Maintained	Buy
Jul 30, 2026	Piper Sandler	David Amsellem—	+38.9%	$88 → $165	Maintained	Overweight
Jul 30, 2026	Canaccord Genuity	Edward Nash—	+35.5%	$150 → $161	Maintained	Buy
Jul 30, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+38.9%	$95 → $165	Maintained	Buy
Jul 29, 2026	Canaccord Genuity	Edward Nash—	+26.2%	$135 → $150	Maintained	Buy
Jul 27, 2026	Wolfe Research	Kalpit Patel—	-57.9%	$50	Downgrade	Peer Perform→Underperform
May 28, 2026	Canaccord Genuity	Edward Nash—	+13.6%	$110 → $135	Maintained	Buy
May 28, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-20.0%	$75 → $95	Maintained	Buy
May 13, 2026	UBS	Ashwani Verma—	-39.4%	$44 → $72	Upgrade	Neutral→Buy
May 4, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-36.9%	$60 → $75	Maintained	Buy
May 1, 2026	Piper Sandler	David Amsellem—	-25.9%	$73 → $88	Maintained	Overweight
Mar 26, 2026	Canaccord Genuity	Edward Nash—	-7.4%	$100 → $110	Maintained	Buy
Mar 26, 2026	Wolfe Research	Kalpit Patel—	—	—	Upgrade	Underperform→Peer Perform
Mar 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-49.5%	$67 → $60	Maintained	Buy
Feb 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-49.5%	$67 → $60	Maintained	Buy
Feb 20, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-43.6%	$105 → $67	Maintained	Buy
Jan 23, 2026	Canaccord Genuity	Edward Nash—	-15.8%	$99 → $100	Maintained	Buy
Jan 23, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-11.6%	$90 → $105	Maintained	Buy
Jan 2, 2026	Canaccord Genuity	Edward Nash—	-16.7%	$140 → $99	Maintained	Buy
Jan 2, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-24.3%	$145 → $90	Maintained	Buy
Dec 16, 2025	UBS	Ashwani Verma—	-20.0%	$95	Initiate	Neutral
Nov 25, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+22.0%	$145 → $145	Maintained	Buy
Nov 18, 2025	Wolfe Research	Kalpit Patel—	—	—	Initiate	Peer Perform
Oct 20, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+22.0%	$145 → $145	Maintained	Buy
Oct 10, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+22.0%	$145 → $145	Maintained	Buy